Dexter JohnsonCOVID-19Plant offers potential for massive scale production of COVID-19 tests, vaccinesResearchers have developed a rapid and flexible agroinfiltration-based platform for the production of recombinant SARS-CoV-2 Spike Receptor-Binding Domain (RBD) in the benthi plant.December 16, 2022COVID-19Biomarkers present at initial COVID-19 infection hint at long COVIDThe researchers believe that these findings underscore the need for greater attention at the infection stage of COVID-19 to better understand the processes that eventually lead to long COVID.December 8, 2022COVID-19Long COVID patients at risk, whether hospitalized or notSpanish researchers reported that the percentage of patients with at least one post–COVID-19 symptom two years after acute infection was 59.7% for hospitalized patients, while the percentage of those who had not required hospitalization was 67.5%.November 16, 2022COVID-19French study confirms long COVID is a public health concernFrench researchers determined that in 10.1% of cases, patients were still suffering symptoms one year after their initial SARS-CoV-2 infection.November 10, 2022Healthcare ReformCDC’s five-day isolation period after COVID infection may not be sufficientStanford University researchers have published findings indicating that rapid antigen tests remained positive in 27% of the participants in a study after seven days of isolation.October 19, 2022COVID-19SARS-CoV-2 molecular tests highly accurate in Canadian studyThe diagnostic sensitivity of these molecular tests suggests that one negative test result can effectively rule out SARS-CoV-2 infection for most patients, the researchers said.October 12, 2022SequencingHarvard NGS technique sheds light on hard-to-isolate cellsThe technique is comparable to single-cell sequencing methods while simultaneously broadening the depth and scope of investigations possible on a tissue sample.October 11, 2022RUODuke University developing RNA-based probe for disease managementThe researchers contend that this tool could become a key technique in the managing of disease by simply modifying cells and their functions. It would offer a disease management tool that currently does not exist.October 7, 2022COVID-19UK researchers propose solution for meeting pandemic testing demandThe researchers are advocating the establishment of a system of reserve lab technicians and volunteers to handle the surge in testing that occurs during a pandemic.October 3, 2022InfectiousGerman study: self-testing effective in fighting SARS-CoV-2Successful long-term participation was highest among a group of study participants that took saliva-based tests.September 14, 2022Page 1 of 2Next PageTop StoriesFDA ClearanceFDA approves CRISPR-based gene therapy, cell-based gene therapy for SCDThe FDA has approved Vertex Pharmaceuticals’ and CRISPR Therapeutics’ CRISPR-based gene-editing therapy for the treatment of VOCs in patients with sickle cell disease (SCD). It is the first CRISPR-based gene therapy to receive FDA approval.Mergers & AcquisitionsPerkinElmer acquires CovarisBusiness InsightsFDA clears BD’s new fingerstick blood collection deviceKickbackTexas lab owner pleads guilty in $1.7M Medicare fraudHepatitisCDC awards contract to Quest Diagnostics to assess hepatitis C burden
